🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/10/2001 65,08 65,08 63,46 63,88 -0,46% 2,48% 4.187.494
22/10/2001 62,40 64,57 62,39 64,18 +2,88% 3,50% 6.177.331
19/10/2001 63,22 63,26 61,78 62,39 -1,39% 2,34% 7.150.714
18/10/2001 64,55 64,84 63,04 63,26 -3,98% 2,78% 7.446.145
17/10/2001 65,66 66,46 65,27 65,89 -0,38% 1,82% 5.373.096
16/10/2001 66,79 67,37 65,55 66,14 -0,91% 2,71% 4.739.370
15/10/2001 65,65 66,79 65,65 66,75 +1,14% 1,74% 4.266.722
12/10/2001 65,12 66,11 64,76 65,99 +1,44% 2,07% 5.057.858
11/10/2001 65,31 65,46 64,45 65,06 -0,45% 1,55% 5.534.174
10/10/2001 64,63 66,03 64,29 65,35 +0,82% 2,69% 4.204.366
09/10/2001 65,17 65,33 64,06 64,82 -0,98% 1,95% 3.728.050
08/10/2001 64,84 65,84 64,68 65,46 +0,50% 1,80% 3.677.013
05/10/2001 64,03 65,27 63,69 65,13 +1,73% 2,46% 4.935.242
04/10/2001 64,63 64,88 63,31 64,03 -0,83% 2,42% 5.656.580
03/10/2001 65,31 65,31 63,24 64,56 -1,14% 3,17% 6.080.601
02/10/2001 65,19 65,33 64,05 65,31 +0,18% 1,98% 4.712.542
01/10/2001 63,79 65,19 63,60 65,19 +2,58% 2,50% 8.254.886
28/09/2001 64,69 64,77 62,18 63,55 +0,59% 4,01% 7.910.304
27/09/2001 61,05 63,87 60,96 63,18 +4,51% 4,77% 6.885.150
26/09/2001 59,58 60,77 59,58 60,45 +1,44% 2,00% 8.072.010
25/09/2001 60,11 61,07 58,06 59,59 -2,41% 5,00% 12.446.362
24/09/2001 62,69 63,60 60,47 61,06 -2,60% 4,99% 10.237.493
21/09/2001 61,07 64,11 60,87 62,69 -1,72% 5,31% 13.921.842
20/09/2001 63,93 64,52 63,55 63,79 -1,49% 1,52% 8.430.741
19/09/2001 65,79 66,07 63,50 64,75 -0,66% 3,90% 9.043.611
18/09/2001 64,07 65,92 63,77 65,18 +1,73% 3,35% 7.641.178
17/09/2001 64,84 64,98 63,12 64,07 +1,59% 2,87% 9.532.084
10/09/2001 61,07 63,45 60,60 63,07 +2,80% 4,67% 5.744.088
07/09/2001 62,36 62,36 61,21 61,36 -2,21% 1,84% 5.074.206
06/09/2001 64,12 64,48 62,51 62,74 -2,88% 3,08% 5.254.358